Literature DB >> 17099700

Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates.

David Reverter1, Christopher D Lima.   

Abstract

SUMO processing and deconjugation are essential proteolytic activities for nuclear metabolism and cell-cycle progression in yeast and higher eukaryotes. To elucidate the mechanisms used during substrate lysine deconjugation, SUMO isoform processing and SUMO isoform interactions, X-ray structures were determined for a catalytically inert SENP2 protease domain in complex with conjugated RanGAP1-SUMO-1 or RanGAP1-SUMO-2, or in complex with SUMO-2 or SUMO-3 precursors. Common features within the active site include a 90 degrees kink proximal to the scissile bond that forces C-terminal amino acid residues or the lysine side chain toward a protease surface that appears optimized for lysine deconjugation. Analysis of this surface reveals SENP2 residues, particularly Met497, that mediate, and in some instances reverse, in vitro substrate specificity. Mutational analysis and biochemistry provide a mechanism for SENP2 substrate preferences that explains why SENP2 catalyzes SUMO deconjugation more efficiently than processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099700     DOI: 10.1038/nsmb1168

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  64 in total

Review 1.  Trojan horse strategies used by pathogens to influence the small ubiquitin-like modifier (SUMO) system of host eukaryotic cells.

Authors:  Miklós Békés; Marcin Drag
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

2.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 3.  Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways.

Authors:  Allan D Capili; Christopher D Lima
Journal:  Curr Opin Struct Biol       Date:  2007-10-04       Impact factor: 6.809

4.  Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction.

Authors:  Allan D Capili; Christopher D Lima
Journal:  J Mol Biol       Date:  2007-04-06       Impact factor: 5.469

Review 5.  SUMOylation and De-SUMOylation: wrestling with life's processes.

Authors:  Edward T H Yeh
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

6.  Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.

Authors:  Christopher D Lima; David Reverter
Journal:  J Biol Chem       Date:  2008-09-16       Impact factor: 5.157

Review 7.  SUMOylation and deSUMOylation at a glance.

Authors:  Yonggang Wang; Mary Dasso
Journal:  J Cell Sci       Date:  2009-12-01       Impact factor: 5.285

8.  Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions.

Authors:  Sarah Schulz; Georgia Chachami; Lukasz Kozaczkiewicz; Ulrike Winter; Nicolas Stankovic-Valentin; Petra Haas; Kay Hofmann; Henning Urlaub; Huib Ovaa; Joachim Wittbrodt; Erik Meulmeester; Frauke Melchior
Journal:  EMBO Rep       Date:  2012-08-10       Impact factor: 8.807

9.  Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway.

Authors:  David M Duda; Robert C A M van Waardenburg; Laura A Borg; Sierra McGarity; Amanda Nourse; M Brett Waddell; Mary-Ann Bjornsti; Brenda A Schulman
Journal:  J Mol Biol       Date:  2007-04-10       Impact factor: 5.469

10.  Identification and characterization of a new chemotype of noncovalent SENP inhibitors.

Authors:  Ikenna G Madu; Andrew T Namanja; Yang Su; Steven Wong; Yi-Jia Li; Yuan Chen
Journal:  ACS Chem Biol       Date:  2013-05-01       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.